Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038)

NCT00566527 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1620

Enrollment

INDUSTRY

Sponsor class

Conditions

Measles
Mumps
Rubella
Varicella

Interventions

BIOLOGICAL: ProQuad® manufactured with recombinant Human Albumin (rHA)

Sponsor

Merck Sharp & Dohme LLC